• Lead the global HEOR and value strategy across pipeline and commercial assets, ensuring alignment with overall corporate, clinical, and access objectives. • Develop and execute integrated evidence generation plans, including economic models, real-world evidence, patient-reported outcomes, and burden-of-disease studies to support pricing, reimbursement, and access decisions. • Oversee the design, development, and maintenance of global value dossiers, HTA submissions, payer value narratives, and supporting materials across key markets. • Partner closely with Clinical Development to embed HEOR endpoints and evidence requirements into clinical trial design and lifecycle planning. • Collaborate with Market Access and Commercial leadership to support pricing strategy, payer engagement, launch readiness, and post-launch optimization. • Serve as a senior internal advisor and escalation point on payer, HTA, and value-related questions, translating complex evidence into clear strategic recommendations. • Build, lead, and mentor a high-performing HEOR and value team, including internal staff and external vendors, consultants, and academic partners. • Ensure all HEOR activities are conducted in compliance with applicable regulations, industry standards, and internal governance frameworks. • Monitor evolving global payer, HTA, and policy landscapes to proactively adapt evidence strategies and inform long-term planning.